{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:11:17Z","timestamp":1780333877280,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00063-025-01290-9","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T09:01:35Z","timestamp":1748422895000},"page":"523-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic Stewardship\u00a0\u2013 ein Update","Antibiotic stewardship\u2014an update"],"prefix":"10.1007","volume":"120","author":[{"given":"Katja","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Nachtigall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-2753","authenticated-orcid":false,"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"10459","key":"1290_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a\u00a0systematic analysis with forecasts to 2050. Lancet 404(10459):1199\u20131226","journal-title":"Lancet"},{"issue":"10325","key":"1290_CR2","first-page":"629","volume":"399","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024) Global burden of bacterial antimicrobial resistance in 2019: a\u00a0systematic analysis. Lancet 399(10325):629\u2013655","journal-title":"Lancet"},{"key":"1290_CR3","unstructured":"(2023) www.bundesgesundheitsministerium.de\/themen\/praevention\/antibiotika-resistenzen\/dart-2030.html. Zugegriffen: 11. Dez. 2024"},{"key":"1290_CR4","doi-asserted-by":"crossref","unstructured":"Zay YaK, Win PTN, Bielicki J, Lambiris M, Fink G (2023) Association between antimicrobial stewardship programs and antibiotic use globally. Jama Netw Open 6(2)","DOI":"10.1001\/jamanetworkopen.2022.53806"},{"key":"1290_CR5","volume-title":"S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. AWMF Leitlinie Update 2018","author":"K De With","year":"2019","unstructured":"De With\u00a0K, Wilke\u00a0K, Kern\u00a0WV et\u00a0al (2019) S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. AWMF Leitlinie Update 2018"},{"issue":"2","key":"1290_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/ice.2023.5","volume":"44","author":"V Fabre","year":"2023","unstructured":"Fabre\u00a0V, Davis\u00a0A, Diekema\u00a0DJ, Granwehr\u00a0B, Hayden\u00a0MK, Lowe\u00a0CF et\u00a0al (2023) Principles of diagnostic stewardship: A\u00a0practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force. Infect Control Hosp Epidemiol 44(2):178\u2013185","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"1290_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/cid\/ciz545","volume":"70","author":"IS Kamat","year":"2020","unstructured":"Kamat\u00a0IS, Ramachandran\u00a0V, Eswaran\u00a0H, Guffey\u00a0D, Musher\u00a0DM (2020) Procalcitonin to distinguish viral from bacterial pneumonia: A\u00a0systematic review and meta-analysis. Clin Infect Dis 70(3):538\u2013542","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1290_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12879-024-09174-7","volume":"24","author":"YC Lee","year":"2024","unstructured":"Lee\u00a0YC, Yeh\u00a0HT, Lu\u00a0SW, Tsai\u00a0YC, Tsai\u00a0YC, Yen\u00a0CC (2024) Diagnostic accuracy of procalcitonin in adult non-neutropenic cancer patients with suspected infection: a\u00a0systematic review and meta-analysis. BMC Infect Dis 24(1):278","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1290_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7150\/ijms.39367","volume":"17","author":"R Paudel","year":"2020","unstructured":"Paudel\u00a0R, Dogra\u00a0P, Montgomery-Yates\u00a0AA, Coz Yataco\u00a0A (2020) Procalcitonin: A\u00a0promising tool or just another overhyped test? Int J Med Sci 17(3):332\u2013337","journal-title":"Int J Med Sci"},{"issue":"7","key":"1290_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong\u00a0E, van Oers\u00a0JA, Beishuizen\u00a0A, Vos\u00a0P, Vermeijden\u00a0WJ, Haas\u00a0LE et\u00a0al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a\u00a0randomised, controlled, open-label trial. Lancet Infect Dis 16(7):819\u2013827","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1290_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13054-023-04677-2","volume":"27","author":"M Papp","year":"2023","unstructured":"Papp\u00a0M, Kiss\u00a0N, Baka\u00a0M, Trasy\u00a0D, Zubek\u00a0L, Fehervari\u00a0P et\u00a0al (2023) Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival\u2011a systematic review and meta-analysis. Crit Care 27(1):394","journal-title":"Crit Care"},{"issue":"7","key":"1290_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/cid\/civ447","volume":"61","author":"R Banerjee","year":"2015","unstructured":"Banerjee\u00a0R, Teng\u00a0CB, Cunningham\u00a0SA, Ihde\u00a0SM, Steckelberg\u00a0JM, Moriarty\u00a0JP et\u00a0al (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61(7):1071\u20131080","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1290_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/cid\/ciae234","volume":"79","author":"AM Peri","year":"2024","unstructured":"Peri\u00a0AM, Chatfield\u00a0MD, Ling\u00a0W, Furuya-Kanamori\u00a0L, Harris\u00a0PNA, Paterson\u00a0DL (2024) Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A\u00a0systematic review and network meta-analysis. Clin Infect Dis 79(2):502\u2013515","journal-title":"Clin Infect Dis"},{"key":"1290_CR14","volume-title":"S3-Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie. AWMF Leitlinie Update 2021","author":"S Ewig","year":"2021","unstructured":"Ewig\u00a0S, Kolditz\u00a0M, Pletz\u00a0M et\u00a0al (2021) S3-Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie. AWMF Leitlinie Update 2021"},{"key":"1290_CR15","volume-title":"S3-Leitlinie Epidemiologie, Diagnostik, Therapie erwachsener Patienten nosokomiale Pneumonie. AWMF Leitlinie Update 2024","author":"J Rademacher","year":"2024","unstructured":"Rademacher\u00a0J, Ewig\u00a0S, Grabein\u00a0B et\u00a0al (2024) S3-Leitlinie Epidemiologie, Diagnostik, Therapie erwachsener Patienten nosokomiale Pneumonie. AWMF Leitlinie Update 2024"},{"issue":"4","key":"1290_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cmi.2019.09.013","volume":"26","author":"E Saarela","year":"2020","unstructured":"Saarela\u00a0E, Tapiainen\u00a0T, Kauppila\u00a0J, Pokka\u00a0T, Uhari\u00a0M, Kauma\u00a0H et\u00a0al (2020) Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a\u00a0randomized clinical trial. Clin Microbiol Infect 26(4):506\u2013511","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"1290_CR17","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.cmi.2023.07.031","volume":"29","author":"L Velly","year":"2023","unstructured":"Velly\u00a0L, Cancella de Abreu\u00a0M, Boutolleau\u00a0D, Cherubini\u00a0I, Houas\u00a0E, Aurousseau\u00a0A et\u00a0al (2023) Point-of-care multiplex molecular diagnosis coupled with procalcitonin-guided algorithm for antibiotic stewardship in lower respiratory tract infection: a\u00a0randomized controlled trial. Clin Microbiol Infect 29(11):1409\u20131416","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1290_CR18","doi-asserted-by":"publisher","first-page":"e13725","DOI":"10.1111\/tid.13725","volume":"24","author":"MZ Kayser","year":"2022","unstructured":"Kayser\u00a0MZ, Seeliger\u00a0B, Valtin\u00a0C, Fuge\u00a0J, Ziesing\u00a0S, Welte\u00a0T et\u00a0al (2022) Clinical decision making is improved by BioFire Pneumonia Plus in suspected lower respiratory tract infection after lung transplantation: Results of the prospective DBATE-IT study. Transpl Infect Dis 24(1):e13725","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"1290_CR19","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","volume":"158","author":"JA Ramirez","year":"2020","unstructured":"Ramirez\u00a0JA, Musher\u00a0DM, Evans\u00a0SE, Cruz\u00a0DC, Crothers\u00a0KA, Hage\u00a0CA et\u00a0al (2020) Treatment of community-acquired pneumonia in immunocompromised adults: A\u00a0consensus statement regarding initial strategies. Chest 158(5):1896\u20131911","journal-title":"Chest"},{"key":"1290_CR20","unstructured":"https:\/\/www.dgi-net.de\/wissenschaft\/klug-entscheiden\/. Zugegriffen: 25. Okt. 2024"},{"key":"1290_CR21","volume-title":"S3-Leitlinie Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei Erwachsenen (HWI). AWMF Leitlinie Uptade 2024","author":"DGU","year":"2024","unstructured":"DGU (2024) S3-Leitlinie Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei Erwachsenen (HWI). AWMF Leitlinie Uptade 2024"},{"issue":"2","key":"1290_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jama.2018.19283","volume":"321","author":"ES Shenoy","year":"2019","unstructured":"Shenoy\u00a0ES, Macy\u00a0E, Rowe\u00a0T, Blumenthal\u00a0KG (2019) Evaluation and Management of Penicillin Allergy: A\u00a0Review. JAMA 321(2):188\u2013199","journal-title":"JAMA"},{"issue":"4","key":"1290_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amjmed.2019.09.017","volume":"133","author":"M DesBiens","year":"2020","unstructured":"DesBiens\u00a0M, Scalia\u00a0P, Ravikumar\u00a0S, Glick\u00a0A, Newton\u00a0H, Erinne\u00a0O et\u00a0al (2020) A closer look at penicillin allergy history: Systematic review and meta-analysis of tolerance to drug challenge. Am J Med 133(4):452\u2013462.e4","journal-title":"Am J Med"},{"issue":"6","key":"1290_CR24","doi-asserted-by":"publisher","first-page":"ofad224","DOI":"10.1093\/ofid\/ofad224","volume":"10","author":"MR Norvell","year":"2023","unstructured":"Norvell\u00a0MR, Porter\u00a0M, Ricco\u00a0MH, Koonce\u00a0RC, Hogan\u00a0CA, Basler\u00a0E et\u00a0al (2023) Cefazolin vs second-line antibiotics for surgical site infection prevention after total joint arthroplasty among patients with a\u00a0beta-lactam allergy. Open Forum Infect Dis 10(6):ofad224","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"1290_CR25","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/jac\/dkz127","volume":"74","author":"RM West","year":"2019","unstructured":"West\u00a0RM, Smith\u00a0CJ, Pavitt\u00a0SH, Butler\u00a0CC, Howard\u00a0P, Bates\u00a0C et\u00a0al (2019) \u2018Warning: allergic to penicillin\u2019: association between penicillin allergy status in 2.3\u00a0million NHS general practice electronic health records, antibiotic prescribing and health outcomes. J\u00a0Antimicrob Chemother 74(7):2075\u20132082","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1290_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1017\/ice.2020.1229","volume":"42","author":"NM Krah","year":"2021","unstructured":"Krah\u00a0NM, Jones\u00a0TW, Lake\u00a0J, Hersh\u00a0AL (2021) The impact of antibiotic allergy labels on antibiotic exposure, clinical outcomes, and healthcare costs: A\u00a0systematic review. Infect Control Hosp Epidemiol 42(5):530\u2013548","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1290_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijid.2022.11.026","volume":"129","author":"N Powell","year":"2023","unstructured":"Powell\u00a0N, Stephens\u00a0J, Kohl\u00a0D, Owens\u00a0R, Ahmed\u00a0S, Musicha\u00a0C et\u00a0al (2023) The effectiveness of interventions that support penicillin allergy assessment and delabeling of adult and pediatric patients by nonallergy specialists: a\u00a0systematic review and meta-analysis. Int J Infect Dis 129:152\u2013161","journal-title":"Int J Infect Dis"},{"issue":"5","key":"1290_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","volume":"180","author":"JA Trubiano","year":"2020","unstructured":"Trubiano\u00a0JA, Vogrin\u00a0S, Chua\u00a0KYL, Bourke\u00a0J, Yun\u00a0J, Douglas\u00a0A et\u00a0al (2020) Development and Validation of a\u00a0Penicillin Allergy Clinical Decision Rule. JAMA Intern Med 180(5):745\u2013752","journal-title":"JAMA Intern Med"},{"issue":"9","key":"1290_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/jamainternmed.2023.2986","volume":"183","author":"AM Copaescu","year":"2023","unstructured":"Copaescu\u00a0AM, Vogrin\u00a0S, James\u00a0F, Chua\u00a0KYL, Rose\u00a0MT, De Luca\u00a0J et\u00a0al (2023) Efficacy of a\u00a0clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: The PALACE randomized clinical trial. JAMA Intern Med 183(9):944\u2013952","journal-title":"JAMA Intern Med"},{"key":"1290_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00063-024-01159-3","volume":"119","author":"J Rademacher","year":"2024","unstructured":"Rademacher\u00a0J, Kluge\u00a0S (2024) 10\u00a0Kernaussagen zur S3-Leitlinie \u201eEpidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie\u201c. Med Klin Intensivmed Notfmed 119:502\u2013505","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"11","key":"1290_CR31","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cmi.2024.05.014","volume":"30","author":"T Schoffelen","year":"2024","unstructured":"Schoffelen\u00a0T, Papan\u00a0C, Carrara\u00a0E, Eljaaly\u00a0K, Paul\u00a0M, Keuleyan\u00a0E et\u00a0al (2024) European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists). Clin Microbiol Infect 30(11):1384\u20131407","journal-title":"Clin Microbiol Infect"},{"key":"1290_CR32","doi-asserted-by":"crossref","unstructured":"R\u00f6denbeck M, Ayobami O, Eckmanns T, Pletz MW, Bleidorn J, Markwart R (2023) Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: a\u00a0systematic review and meta-analysis, 1\u00a0January 2010 to 31\u00a0December 2021. Euro Surveill 28(20)","DOI":"10.2807\/1560-7917.ES.2023.28.20.2200672"},{"key":"1290_CR33","unstructured":"https:\/\/infectiouscongress.com\/program\/scientific-program\/2025\/single-site-sampling-strategy-versus-multi-site-sampling-strategy-in-blood-culture-collection-within-the-hospital-setting-a-systematic-review. Zugegriffen: 8. Jan. 2025"},{"key":"1290_CR34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3389\/fmicb.2020.01639","volume":"11","author":"D Yu","year":"2020","unstructured":"Yu\u00a0D, Larsson\u00a0A, Parke \u00c5, Unge\u00a0C, Henning\u00a0C, Sund\u00e9n-Cullberg\u00a0J et\u00a0al (2020) Single-sampling strategy vs. multi-sampling strategy for blood cultures in sepsis: A\u00a0prospective non-inferiority study. Front Microbiol 11:1639","journal-title":"Front Microbiol"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-025-01290-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-025-01290-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-025-01290-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:59:45Z","timestamp":1770649185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-025-01290-9"}},"subtitle":["Weiterentwicklung einer Initiative","Ongoing development of an initiative"],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1007\/s00063-025-01290-9","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die Originalversion dieses Beitrags wurde korrigiert. Die Frage 3 im CME-Fragebogen wurde von \u201eEin Patient mit kulturell best\u00e4tigter Staphylococcus aureus-Blutstrominfektion (nichmethicillinresistent, MRSA) erh\u00e4lt aufgrund einer anamnestisch angegebenen Penizillinallergie Vancomycin i.v. als Antibiotikatherapie.  Welche Empfehlung geben Sie w\u00e4hrend der w\u00f6chentlichen AntibioticStewardship(ABS)-Visite den Kollegen auf Station?\u201c zu \u201eEin Patient mit kulturell best\u00e4tigter Staphylococcus aureus-Blutstrominfektion (Methicillin-sensibler Staphylococcus aureus [MSSA]) erh\u00e4lt aufgrund einer anamnestisch angegebenen Penizillinallergie Vancomycin i.v. als Antibiotikatherapie. Welche Empfehlung geben Sie w\u00e4hrend der w\u00f6chentlichen Antibiotic-Stewardship(ABS)-Visite den Kollegen auf Station?\u201c korrigiert.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00063-026-01421-w","URL":"https:\/\/doi.org\/10.1007\/s00063-026-01421-w","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"K.\u00a0Schneider\n                      : A.\u00a0Finanzielle Interessen: Reisestipendium von der DGIM 04\/2024 \u00fcber 250\u202f\u20ac als Posterreferentin.\u00a0\u2013 B. Nichtfinanzielle Interessen: Fach\u00e4rztin f\u00fcr Innere Medizin, Institut f\u00fcr Infektionsmedizin und Krankenhaushygiene, Universit\u00e4tsklinikum Jena, Friedrich-Schiller-Universit\u00e4t Jena, Jena | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin; Deutsche Gesellschaft f\u00fcr Infektiologie.\n                      S.\u00a0Hagel\n                      : A.\u00a0Finanzielle Interessen: S.\u00a0Hagel gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B. Nichtfinanzielle Interessen: leitender Oberarzt, Internist, Infektiologe, Krankenhaushygieniker, ABS-Experte (DGI), Institut f\u00fcr Infektionsmedizin und Krankenhaushygiene, Universit\u00e4tsklinikum Jena.\n                      J.\u00a0Rademacher\n                      : A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: BMBF (Bundesministerium f\u00fcr Bildung und Forschung), BMG (Bundesministerium f\u00fcr Gesundheit), Infectopharm, Insmed.\u00a0\u2013 Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Chiesi, GILEAD, GlaxoSmithKline, MedUpdate, MSD, Pfizer, Sanofi, Seqirus, Shionogi, Streamed Up, Thermo Fisher Scientific.\u00a0\u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00e4.: Advanz Pharma, GILEAD, GlaxoSmithKline, Insmed, Sanofi, Shionogi, Thermo Fischer Scientific.\u00a0\u2013 B. Nichtfinanzielle Interessen: niedergelassen mit Sitz in Hamburg, angestellt bei der Medizinischen Hochschule Hannover | Vorstand: PROGNOSIS (Deutsches Bronchiektasen-Register) | Mitgliedschaften: DGP, ERS.\n                      I.\u00a0Nachtigall\n                      : A.\u00a0Finanzielle Interessen: Vortragshonorare: Pfizer, Advanz, Shionogi, InfectoPharm alle an ihr Forschungskonto bei Vivantes, keine privaten Anteile.\u00a0\u2013 B. Nichtfinanzielle Interessen: Leiterin der Abteilung Translationale Forschung, Lehre und Kooperation, Vivantes Netzwerk f\u00fcr Gesundheit GmbH, Berlin | Mitglied und Delegierte EUCIC des ESCMID der DGI; Paul-Ehrlich-Gesellschaft Leitung Arbeitsgemeinschaft Antibiotic Stewardship; Spitzenfrauen Gesundheit (aktives Mitglied); Deutscher \u00c4rztinnenbund (aktives Mitglied); Aktionsb\u00fcndnis Patientensicherheit.\n                      M.\u00a0Pletz\n                      : A.\u00a0Finanzielle Interessen: Pfizer, Grant f\u00fcr eine Studie zur Krankheitslast der Pneumonie.\u00a0\u2013 Referentenhonorar: Pfizer, MSD, Shionogi, GSK, Novartis, Thermo Fisher, biomerieux, Advanzpharma, Infectopharm.\u00a0\u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00e4.: biomerieux, Sanofi.\u00a0\u2013 B. Nichtfinanzielle Interessen: Direktor des Instituts f\u00fcr Infektionsmedizin und Krankenhaushygiene, Universit\u00e4tsklinikum Jena | Past-Pr\u00e4sident Paul-Ehrlich-Gesellschaft, Vorstand CAPNETZ, Vorstand Deutsche Sepsis Gesellschaft, Beirat Infectognotics, Sprecher Else Kr\u00f6ner Fresenius Forschungskolleg zu Endokarditis, Host Podcast Consilium Infectiorum, Herausgeber der\n                      Zeitschrift f\u00fcr Infektionstherapie\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}